PharmiWeb.com - Global Pharma News & Resources

Company Directory

PharmiWeb's Pharma Company Directory is a comprehensive and searchable listing of organisations within the Pharma, Biotech & Life Sciences sector. Use it to find partner organisations, suppliers, or even a company to work for!

As an organisation, a basic listing is FREE, and can raise your profile in the industry, making you visible to thousands of monthly site visitors.

To add your organisation to the directory, simply register as a contributor and add your organisation's details. 

Note that we only accept contributions relating to the Pharma industry and that it will typically take 2 working days to approve (or otherwise) your details. Once approved, you will also be able to contribute press releases and event details to our site. Our desision is final.

Create a free account to list your company for free!

At Apellis, we are committed to developing transformative therapies for people living with a broad range of debilitating diseases by controlling complement, part of the body’s immune system. Our work is rooted centrally at C3, which is the only target in the complement cascade that addresses all three pathways that can drive disease.
We make patient lives better, by enabling and accelerating access to medicines and enhanced care services, through programmes designed and delivered in partnership with our pharmaceutical clients. All Apodi programmes provide invaluable support to our NHS in its management of their patients.
Founded in 1974 by Dr. Barry Sherman, we’re a proudly Canadian, global pharmaceutical company that produces high-quality, affordable medicines (both generic and innovative pharmaceuticals) for patients around the world. From our humble origins of only two employees, we’ve grown to employ more than 8,000 people worldwide in manufacturing, R&D and commercial operations.
Applied Healthcare Research Management Inc. (AHRM) is a specialty CRO with a focus in Health Economics and Outcomes Research. AHRM Inc. has a proven record for conducting both clinical trials and outcomes research across major therapeutic categories throughout North America, Europe and Latin America.
Aprecia is the global leader in commercial-scale 3DP for pharmaceutical manufacturing technology. We’re committed to creating new solutions for unmet healthcare needs by developing pharma-ready innovations and complementary technology platforms that enable patient-centric products and help take medicine to its fullest potential.
We provide the world’s leading life sciences companies physician access, market insights, and strategic solutions that help translate clinical development into commercial success and life-changing cancer treatments.
The pharmaceutical company based in Northern Germany specializes in development, registration, manufacturing and distribution of oncology products. Our portfolio includes the most important generics to treat most common forms of cancer.
Aqilion is a biotech company that focuses on developing new innovative treatments for diseases caused by chronic inflammation and dysfunctional immune reactions such as autoimmune diseases. The company is mainly active in the early phases of drug discovery, from idea to early clinical development.
Whether large pharma or biotech, an agrochemical or animal health company, we provide you global resources and proven capabilities at every stage of the biopharma lifecycle, in small and large molecules. Our ability to offer end-to-end solutions or support standalone programs is underpinned by an innovation mindset, enabling technologies, and a partnership approach to every engagement.
Arcellx is a clinical-stage biopharmaceutical company developing novel, adaptive and controllable cell therapies for the treatment of patients with cancer and autoimmune diseases. Arcellx’s vision is to bring ARC-SparX platform cell therapies to millions of patients who can self-administer prescribed SparX proteins under the care of academic and community practices.
Arcus was founded in 2015 with the vision of bringing together scientists, physicians, advisors, and other leaders with significant content-matter expertise to focus on developing highly combinable, best-in-class cancer therapies.
Arevipharma GmbH is a German, medium-sized manufacturer of active pharmaceutical ingredients and intermediate products with a long tradition in Radebeul near Dresden. The origins go back to the founding of the Heyden chemical factory in 1874.